“Importantly, our balance sheet and growing revenue enable us to make strategic investments in both our computational platform and our internal pipeline to build for the future.”ĭelivered strong operating performance and strategic execution Looking across multiple key indicators, we believe our underlying business is poised for continued growth this year,” said Joel Lebowitz, chief financial officer at Schrödinger. “We finished 2020 in a strong financial position. We believe this growth reflects the power of our physics-based platform to accelerate the discovery of new medicines and materials,” stated Ramy Farid, Ph.D., chief executive officer at Schrödinger.
#Schrodinger suites 2019 software
Software revenue increased substantially, and we expect continued growth in 2021. “2020 was a very strong year for Schrödinger across all aspects of our business.
#Schrodinger suites 2019 full
(Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced financial results for the fourth quarter and full year ended December 31, 2020, and provided its financial outlook for 2021. Internal pipeline progressing, with plans to submit investigational new drug applications in 2022Ĭonference call today, Thursday, March 4, at 8:30 a.m. Strong financial position enables continued investment in advancing the science underlying Schrödinger’s computational platform Software revenue of $92.5 million in 2020, up 39 percent year-over-year Total revenue of $108.1 million in 2020, up 26 percent year-over-year
0 kommentar(er)
